Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3263106 | Method For Suppressing Bitterness Of Quinoline Derivative | EISAI R&D MANAGEMENT CO., LTD. | Jul 12, 2024 |
EP3626270 | New Use | NOVARTIS AG | Jul 10, 2024 |
EP3634463 | Improved Protocol For Treatment Of Lupus Nephritis | AURINIA PHARMACEUTICALS INC. | Jun 26, 2024 |
EP3370729 | Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma | CELGENE CORPORATION | Jun 25, 2024 |
EP3110449 | Medical Use Of A Dpp-4 Inhibitor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Mar 21, 2024 |
EP3858405 | Syringe | NOVARTIS AG | Jan 5, 2024 |
EP3294283 | Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure | NOVARTIS AG | Dec 7, 2023 |
EP2981272 | Microporous Zirconium Silicate And Diuretics For The Reduction Of Potassium And Treatment Of Chronic Kidney And/Or Chronic Heart Disease | ZS PHARMA, INC | Nov 22, 2023 |
EP3880197 | Methods Of Treatment For Cystic Fibrosis | VERTEX PHARMACEUTICALS INCORPORATED | Nov 22, 2023 |
EP3752510 | Macrocycles As Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions Thereof, Their Use In The Treatment Of Cycstic Fibrosis, And Process For Making Them | VERTEX PHARMACEUTICALS INCORPORATED | Sep 7, 2023 |
Feel free to send us a message here and we will get back to you